Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Earnings
  • News

ARCA biopharma FY EPS $(0.69) Up From $(1.39) YoY; Cash & Cash Equivalents Of $42.4M Sufficient To Fund Its Operations Through The Middle Of 2024

By Benzinga Newsdesk
Today, 9:08 PM
ARCA biopharma (NASDAQ:ABIO) reported quarterly losses of $(0.69) per share. This is a 50.36 percent increase over losses of $(1.39) per share from the same period last year.

ABIO

Read More
1 minute read
  • Earnings
  • News

ARCA biopharma Q3 EPS $(0.16) Up From $(0.33) YoY

By Michael Horton
Today, 9:08 PM
ARCA biopharma (NASDAQ:ABIO) reported quarterly losses of $(0.16) per share. This is a 51.52 percent increase over losses of $(0.33) per share from the same period last year.

ABIO

Read More
1 minute read
  • Earnings
  • News

ARCA biopharma Q2 EPS $(0.22) Up From $(0.34) YoY

By Benzinga Newsdesk
Today, 9:08 PM
ARCA biopharma (NASDAQ:ABIO) reported quarterly losses of $(0.22) per share. This is a 35.29 percent increase over losses of $(0.34) per share from the same period last year.

ABIO

Read More
2 minute read
  • Movers

12 Health Care Stocks Moving In Friday’s After-Market Session

By Benzinga Insights
Today, 9:08 PM
Gainers Travere Therapeutics (NASDAQ:TVTX) stock increased by 16.5% to $28.87 during Friday's after-market session. The market value of their outstanding shares is at $1.8 billion.

ABIO

Read More
2 minute read
  • Movers

12 Health Care Stocks Moving In Monday’s After-Market Session

By Benzinga Insights
Today, 9:08 PM
Gainers Rockwell Medical (NASDAQ:RMTI) stock rose 9.2% to $0.4 during Monday's after-market session. The company's market cap stands at $37.5 million.

ABIO

Read More
3 minute read
  • Intraday Update
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Small Cap
  • Trading Ideas

38 Stocks Moving In Friday’s Mid-Day Session

By Lisa Levin
Today, 9:08 PM
Gainers Manning & Napier, Inc. (NYSE: MN) jumped 40.7% to $12.82 after the company reported it will be acquired by Callodine Group and will go private at $12.85 per share.

ABIO

Read More
3 minute read
  • Commodities
  • Earnings
  • Eurozone
  • Global
  • Intraday Update
  • Markets
  • News
  • Penny Stocks
  • Small Cap

Mid-Morning Market Update: Markets Higher; US Economy Adds 431,000 Jobs In March

By Lisa Levin
Today, 9:08 PM
U.S. stocks opened higher this morning following the release of non-farm payroll data for March.

ABIO

Read More
1 minute read
  • Markets
  • Movers
  • Pre-Market Outlook

12 Health Care Stocks Moving In Friday’s Pre-Market Session

By Benzinga Insights
Today, 9:08 PM
 

ABIO

Read More
32 minute read
  • Intraday Update
  • Markets
  • Movers
  • News
  • Options
  • Trading Ideas

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights
Today, 9:08 PM
    On Thursday, 615 stocks hit new 52-week lows.

AAOI

Read More
1 minute read
  • Legal
  • Movers
  • News
  • Trading Ideas

ARCA bio Shares Spike Higher Following Circulation Of European Patent Office Register Doc For Co.’s ‘METHODS AND COMPOSITIONS INVOLVING BUCINDOLOL FOR THE TREATMENT OF ATRIAL FIBRILLATION’

By Benzinga Newsdesk
Today, 9:08 PM
https://register.epo.org/application?number=EP19808220&tab=main

ABIO

Posts navigation

1 2 3 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service